
Anusha Kalbasi, MD
University of California, Los Angeles
2017
$
50000
Tower Career Development Grant
Developing a Neoadjuvant Platform to Study Macrophage-Driven Resistance
Immunotherapy is an exciting development in cancer treatment, but has not yet made its mark in sarcoma. The resistance of sarcoma to immunotherapy might be related to the presence of macrophages –a type of immune cell. Here, we aim to understand why sarcomas are full of macrophages, and how macrophages impede the immune system. We will determine how radiation therapy, which is commonly used for patients before surgery, affects these phenomena. Our ultimate goal is to design clinical trials to test drugs targeting macrophages in combination with radiation to make immunotherapy relevant for sarcoma.
Support the Journey
When you donate to Tower, you’re not supporting a single study. You’re part of an ecosystem that believes the next breakthrough is out there, waiting for someone to believe in it first. Every gift puts resources directly behind the discoveries that would otherwise never see the light of day.